Tongue cancer
MONDO:0004631A malignant neoplasm affecting the tongue. The vast majority of cases are carcinomas.
Also known as: cancer of tongue, malignant neoplasm of tongue, malignant tongue neoplasm, malignant tongue tumor, malignant tongue tumour, malignant tumor of the tongue, malignant tumor of tongue, malignant tumour of the tongue
2985 clinical trials for this condition and its sub-types, 26 tagged with Tongue cancer itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
Sub-types of Tongue cancer
-
Tongue squamous cell carcinoma 9 trials · 13 incl. sub-types
1 sub-type
-
Tongue carcinoma 4 trials
-
New combo therapy aims to extend life in advanced head and neck cancer
Disease control OngoingThis phase 3 trial tested whether adding bevacizumab to standard chemotherapy helps people with head and neck cancer that has returned or spread. About 403 adults took part. The main goal was to see if the combination improved overall survival compared to chemotherapy alone.
Phase 3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
New surgical flap aims to restore swallowing and speech in obese tongue cancer patients
Disease control OngoingThis pilot study tests a new surgical technique called the anterolateral thigh myofascial fat composite flap (ALT-MF) for repairing tongue defects after cancer surgery in obese patients (BMI 30 or higher). Traditional flaps can be too bulky in obese patients, leading to problems …
Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Radioactive seeds zapped tumors from inside – early trial shows promise
Disease control OngoingThis study is testing a device called DaRT that delivers alpha radiation directly into tumors. It is for people with skin cancer, mouth tumors, or superficial soft tissue sarcoma who have not responded to other treatments or cannot have standard therapy. The goal is to see if the…
Sponsor: Alpha Tau Medical LTD. • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Can a targeted antibody boost Radiation's power against head and neck cancer?
Disease control OngoingThis phase III trial studies whether adding the drug cetuximab to modern radiation therapy improves survival for people with advanced head and neck cancer that has been surgically removed. About 700 participants received either radiation alone or radiation plus cetuximab. The stu…
Phase 3 • Sponsor: Radiation Therapy Oncology Group • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC